The Low Potential for Drug Interactions with Zanamivir
- 1 January 1999
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 36 (1), 41-50
- https://doi.org/10.2165/00003088-199936001-00005
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Pharmacokinetics of Zanamivir After Intravenous, Oral, Inhaled or Intranasal Administration to Healthy VolunteersClinical Pharmacokinetics, 1999
- 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitroAntimicrobial Agents and Chemotherapy, 1993
- Stereoselective sulfoxidation by human flavin-containing monooxygenase. Evidence for catalytic diversity between hepatic, renal, and fetal forms.1992
- Differential oxidase activity of hepatic and pulmonary microsomal cytochrome P-450 isozymes after treatment with cytochrome P-450 inducersBiochemical and Biophysical Research Communications, 1992
- Enzyme induction in the cytochrome P-450 systemPharmacology & Therapeutics, 1990
- Antihistaminics, local anesthetics, and other amines as antiviral agents.Proceedings of the National Academy of Sciences, 1981
- Binding of Drugs to Serum AlbuminNew England Journal of Medicine, 1976